Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(23/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(23/week)
News
United States
(594/week)
Manufacturing
(436/week)
Energy
(328/week)
Technology
(473/week)
Other Manufacturing
(362/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
CHEK1
Sep 30, 2019
Synthetic Lethality-based Drugs and Targets Market, 2030
May 15, 2019
Sierra to Present SRA737 Preliminary Clinical Data and Potential Next Steps at ASCO
Jan 23, 2019
Sierra Oncology to Present at the DNA Damage Response Therapeutics Summit
Nov 29, 2018
Sierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
Aug 07, 2018
Sierra Oncology to Present at the Wedbush PacGrow Healthcare Conference in New York
May 10, 2018
Sierra Oncology Reports First Quarter Results
Apr 17, 2018
Sierra Late-Breaking Data Demonstrating SRA737 Preclinical Activity with PARPi to be Presented at the AACR 2018 Annual Meeting
Mar 19, 2018
Sierra Oncology to Present at the Future Leaders in the Biotech Industry Conference in New York
Mar 14, 2018
Late-Breaking Abstract Reporting SRA737 Preclinical Activity in CCNE1-Driven and PARPi-Resistant Cancers Accepted for AACR 2018 Annual Meeting
Feb 27, 2018
Sierra Oncology Reports 2017 Year End Results
Feb 27, 2018
Sierra Oncology and Janssen Sign Supply Agreement for Prostate Cancer Study
Feb 21, 2018
Sierra to Report Preclinical Data Demonstrating SRA737 Synergy with PARPi at the AACR 2018 Annual Meeting
Feb 06, 2018
Sierra Oncology to host Program Update in New York on February 27th
Jan 29, 2018
Sierra Oncology to Present at the DNA Damage Response Therapeutics Summit
Nov 08, 2017
Sierra Oncology Reports Third Quarter Results
Nov 07, 2017
Sierra Oncology to Present at the Jefferies 2017 London Healthcare Conference
Oct 30, 2017
Sierra Oncology Reports Preclinical Data for its Chk1 Inhibitor SRA737 Supporting its Ongoing Clinical Development Strategy
Oct 25, 2017
Sierra Oncology Appoints Dr. Andrew Allen to its Board of Directors
Oct 16, 2017
Sierra Oncology to Report Chk1 Inhibitor SRA737 Preclinical Data at AACR-NCI-EORTC 2017
Oct 11, 2017
Sierra Oncology to Present at the 2017 BIO Investor Forum
Page 1
››
Latest News
May 3, 2024
Forum Energy Technologies Announces First Quarter 2024 Results, Benefits from Variperm Acquisition
May 3, 2024
Kolibri Global Energy Announces Annual 2023 Net Income of US$19.3 Million and Adjusted EBITDA of $39.1 Million
May 3, 2024
Alliant Energy Announces First Quarter 2024 Results
May 3, 2024
Illinois American Water Proudly Recognizes American Water Charitable Foundation 2024 Water and Environment...
May 3, 2024
First Two WorldView Legion Spacecraft Performing Well After Launch
May 3, 2024
Terran Orbital Strategic Review is Ongoing
May 3, 2024
AeroVironment, Inc. to Present at the Bank of America Transportation, Airlines, and Industrials Conference
May 3, 2024
Delek US Holdings Increases Regular Quarterly Dividend
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events